MedTrace Logo

Class II Correction Study Using the Invisalign System

NCT02376829 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2023-05-06

Study results available
· View outcomes & findings →

Summary

To demonstrate that growing teenagers which present up to full cusp Class II malocclusions can be treated using the Invisalign System.

Conditions

  • Malocclusion

Interventions

DEVICE

Invisalign System

The Invisalign® System is indicated for the alignment of teeth during orthodontic treatment of malocclusion

Sponsors & Collaborators

  • Align Technology, Inc.

    lead INDUSTRY

Principal Investigators

  • Sherri Wilson-Lopes · Align Technology, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
11 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2021-11-23
Completion
2021-11-23
FDA Device
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02376829 on ClinicalTrials.gov